#37497
#37498
Re: Farmas USA
quita, quita, menudo marronazo pedirle a alguien que se empolle esta empresa.
Anda que no tiene miga.
Si ya sabemos lo que hay.
edito: ya te lo digo yo, nos vamos al cash puro y duro que le queda a la empresa. 1,25-1,30
Luz al final del tunel? acordaos de ARNA cuando recibio el "no" de la FDA
estos son farmas ! aqui hasta que no llega un chapter 11 puede pasar de todo
#37499
Re: Farmas USA
MSTX
--->> Haciendo un Golden Cross MM.50/100
http://stockcharts.com/h-sc/ui
El prox 04/11/ Presenta Q-3 q se espera sea + y despues debe presentar F-III y despues FDA
La tiene clavada en 0.48/0.50 desde hace huuuu creo sea atraves Trading Software
SHORT SHELLING INSTEREST EN PICADA----> vease el grafico
http://www.nasdaq.com/symbol/mstx/short-interest
Re: Farmas Orphan Drug
MSTX
Some Very Good DD about this Situation:
Some DD information for the thoughtful investor...
One of the most exciting biotechnology companies in the market today is Mast Therapeutics (MSTX), a little known company developing an Orphan designated investigational agent (MST-188) that has potential to reduce ischemic tissue injury and end organ damage by restoring microvascular function. MSTX's current clinical focus is on two Orphan diseases: Sickle Cell Anemia ("SCD") and Acute Limb Ischemia ("ALI"). MSTX has already received Orphan Designation for SCD in the U.S and EU, and for ALI in the EU. The stock currently trades at 30 percent below its cash position, has no debt, and existing financial resources are more than adequate to fund the ongoing Phase 3 study in SCD, Phase 2 study in ALI, as well as additional studies for other indications. With a potential pharmaceutical treatment for multiple medical conditions affecting millions worldwide, MSTX is a significantly undervalued biotech with exponential upside.
#37500
Re: Farmas USA
#37501
Re: Farmas USA
En esta semana los reports financieros del Q3 de casi todas
Ando en modo movil, no se si veis este link
http://www.thestreet.mobi/story/12091327/1/uh-oh-arena-pharma-q3-belviq-sales-just-48m.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+(TheStreet.com+Latest+Headlines)
Pero estos datos ya estan descontados en el precio, no?
Vamos, que ya sabe lo que pasaba con las ventas,
No es sorpresa. Pero supongo que habra sangria, si se puede tener mas ....
ARNA
#37502
Re: Farmas USA
#37503
Re: Farmas USA
Voy a chaparme lo de ARNA, luego os cuento mi vision
ZLCS, resultados positivos para Z944 Phase 1b Clinical Study in Pain.
http://boardvote.com/symbol/ZLCS/communique/477127
+10% en premarket.
Aye rme estaba tentando...despertando mi instinto....juas! juas !!
#37504